Please select the option that best describes you:
Is there a role at this time for chemo-immunotherapy in the upfront treatment of classic Hodgkin lymphoma?
Although not approved, for example, are you every using AVD-nivolumab?
Although not approved, for example, are you every using AVD-nivolumab?